secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cocrystal Pharma, Inc. (COCP)
CIK:        0001412486
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001641172-25-027246
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cocrystal Pharma announces up to $13M registered direct offering at $1.70/share
-------------------------------------------------------------------------------

- $4.7M upfront from sale of 2,764,710 shares at $1.70; closing expected Sep 15, 2025.
- Concurrent private placement of warrants to purchase up to 5,529,420 shares at $1.50, exercisable on issuance, 24-month term.
- Potential additional gross proceeds of ~$8.3M if warrants fully exercised on cash basis.
- H.C. Wainwright & Co. acting as exclusive placement agent.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/0001641172-25-027246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-027246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer